Active Pharmaceutical Ingredient

Lenvatinib

Also known as: Lenvima; E7080

CAS: 417716-92-8 Kinase Inhibitor / Antineoplastic IP / BP / EP / USP GMP Certified Aurangabad, Maharashtra, India
Lenvatinib API — Mediocon Inc
Lenvatinib — Pharmaceutical Grade API

Product Overview

CAS No: 417716-92-8  |  MF: C₂₁H₁₉ClN₄O₄  |  MW: 426.85 g/mol

Lenvatinib is a pharmaceutical-grade active ingredient classified as Kinase Inhibitor / Antineoplastic. Mediocon Inc supplies high-purity Lenvatinib API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

  • Multi-target receptor tyrosine kinase inhibitor
  • IP/BP/EP/USP compliant
  • Full CoA and MSDS documentation
  • GMP certified manufacturing

Applications

  • Differentiated thyroid cancer
  • Hepatocellular carcinoma
  • Renal cell carcinoma

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameLenvatinib
Also Known AsLenvima; E7080
CAS Number417716-92-8
Chemical Name4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide
Molecular FormulaC₂₁H₁₉ClN₄O₄
Molecular Weight426.85 g/mol
CategoryKinase Inhibitor / Antineoplastic
AppearanceWhite to yellowish-white powder
SolubilitySlightly soluble in water
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement
💬
Mediocon AI
Hello 👋 How can I help you today?